V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240000620 | 240000620 | null | null | null | null | 2017-03-28 | null | null | null | AML19 TRIAL | 101250493 |
| 240000621 | 240000621 | 1.6 | 74 | Curative (C) | null | 2017-05-30 | null | N | N | AML19 TRIAL | 101226935 |
| 240000622 | 240000622 | 1.67 | 87.7 | Palliative (P) | null | 2019-05-29 | null | 02 | N | METHOTREXATE | 100850288 |
| 240000624 | 240000624 | null | 16.2 | Curative (C) | null | 2017-01-04 | CYTARABINE + DAUNORUBICIN | 01 | N | TRIAL UNSPECIFIED | 100950899 |
| 240000643 | 240000643 | null | null | null | null | 2018-05-28 | DA | null | null | CYTARABINE + DAUNORUBICIN | 100558527 |
| 240000644 | 240000644 | null | null | null | null | 2016-04-12 | LIPOSOMAL DOXORUBICIN | null | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101332769 |
| 240000651 | 240000651 | 1.69 | 62.8 | Curative (C) | null | 2017-04-02 | null | 02 | N | AML18 TRIAL | 101351434 |
| 240000653 | 240000653 | 1.5 | 154.3 | Curative (C) | null | 2019-01-04 | null | 02 | null | BENDAMUSTINE + RITUXIMAB | 100732141 |
| 240000654 | 240000654 | null | null | null | null | 2017-06-20 | CHOP R - 21 days | null | null | CYTARABINE + DAUNORUBICIN | 100820021 |
| 240000660 | 240000660 | 1.82 | 55.2 | Curative (C) | null | 2019-09-08 | null | 02 | N | GEMTUZUMAB OZOGAMICIN | 100834579 |
| 240000664 | 240000664 | 1.83 | 55 | Disease modification (D) | null | 2018-12-13 | CHOP R | 02 | N | CLADRIBINE | 100692177 |
| 240000665 | 240000665 | null | null | null | null | 2018-03-21 | null | null | null | TRIAL | 101312273 |
| 240000667 | 240000667 | 1.77 | 75 | Palliative (P) | 2019-01-25 | 2019-01-30 | CYTARABINE + DAUNORUBICIN | 02 | N | AZACITIDINE | 100696704 |
| 240000674 | 240000674 | 1.68 | 66 | Curative (C) | null | 2018-09-26 | CHOP R | null | N | DA | 100759858 |
| 240000676 | 240000676 | 1.68 | 110 | Curative (C) | null | 2019-04-10 | AML MyeChild 01 A Mitozantrone/Cytarabine + GO | 01 | N | AML19 TRIAL | 100961471 |
| 240000679 | 240000679 | 1.62 | 82 | Curative (C) | 2017-04-19 | 2017-04-21 | null | 02 | N | CHOP R | 101787013 |
| 240000681 | 240000681 | null | null | null | null | 2018-07-11 | IDARUBICIN + TRETINOIN | null | null | CHOP R | 101809011 |
| 240000683 | 240000683 | 1.64 | 75.9 | Palliative (P) | 2019-01-28 | 2019-01-29 | null | 02 | N | CHOP R | 100169000 |
| 240000696 | 240000696 | 1.82 | 8.2 | 03 | 2017-10-01 | 2017-10-05 | IDARUBICIN + TRETINOIN | 02 | N | BORTEZOMIB | 101592742 |
| 240000700 | 240000700 | 1.65 | 78 | Curative (C) | 2019-05-23 | 2019-05-23 | null | 02 | N | LIPOSOMAL DAUNORUBICIN + LIPOSOMAL CYTARABINE (VYXEOS) | 100539124 |
| 240000701 | 240000701 | null | 88 | Curative (C) | 2019-06-20 | 2019-06-20 | CHOP R - 21 days | 02 | N | ALL UKALL2011 TRIAL | 101074700 |
| 240000706 | 240000706 | 1.64 | 91 | Curative (C) | null | 2016-07-12 | AML MyeChild 01 A Mitozantrone/Cytarabine | 02 | N | CABOZANTINIB | 100289721 |
| 240000707 | 240000707 | 1.65 | 67 | Curative (C) | null | 2018-01-22 | AML MyeChild 01 IT Cyt | 02 | null | CHOP R | 101359183 |
| 240000709 | 240000709 | null | null | null | null | 2019-02-12 | Methotrexate intrathecal | null | null | IMATINIB | 101803620 |
| 240000712 | 240000712 | null | null | null | null | 2019-05-28 | FLAG + Idarubicin | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100263938 |
| 240000716 | 240000716 | null | null | null | null | 2019-10-01 | AML MyeChild 01 A Mitozantrone/Cytarabine | null | null | AML18 TRIAL | 101306205 |
| 240000719 | 240000719 | 1.64 | null | Curative (C) | 2019-05-10 | 2019-05-10 | CHOP - 21 days | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101738381 |
| 240000722 | 240000722 | 1.6 | 114 | Curative (C) | 2018-08-24 | 2018-08-25 | null | 02 | N | AZACITIDINE | 100288773 |
| 240000723 | 240000723 | null | null | null | null | 2019-07-25 | CHOP | null | null | AZACITIDINE | 101743976 |
| 240000724 | 240000724 | 1.61 | 54.9 | Curative (C) | null | 2019-12-07 | FLAG | 02 | N | CHOP R | 100833427 |
| 240000731 | 240000731 | 1.73 | 74.8 | Palliative (P) | 2019-09-21 | 2019-09-22 | null | 99 | N | CYTARABINE + FLUDARABINE + IDARUBICIN | 100141412 |
| 240000745 | 240000745 | 1.75 | 86.65 | Curative (C) | 2015-07-14 | 2017-04-21 | CHOEP - 21 days | N | N | DA | 101871026 |
| 240000763 | 240000763 | 1.71 | 80.4 | Palliative (P) | 2017-11-26 | 2017-11-30 | null | Y | N | FCR | 100018754 |
| 240000765 | 240000765 | null | 16.2 | Palliative (P) | 2018-02-14 | 2018-02-15 | Azacitidine | 02 | N | HYDROXYCARBAMIDE | 101260260 |
| 240000767 | 240000767 | null | null | null | 2018-06-01 | 2018-06-03 | null | 02 | null | AML16 TRIAL | 100811942 |
| 240000771 | 240000771 | 1.9 | 70.8 | Curative (C) | null | 2016-09-17 | CYTARABINE + DAUNORUBICIN | N | N | AML18 TRIAL | 100114324 |
| 240000783 | 240000783 | 1.71 | 95 | 03 | null | 2019-01-31 | Triple / Double Intrathecal Therapy | 02 | N | AML19 TRIAL | 100223396 |
| 240000785 | 240000785 | 1.79 | 67.2 | Curative (C) | null | 2017-12-25 | CYTARABINE + DAUNORUBICIN | 02 | N | CHOP R | 100561983 |
| 240000791 | 240000791 | 1.57 | 61.6 | Curative (C) | 2018-10-22 | 2018-10-23 | Chlorambucil | N | N | AML19 TRIAL | 101496728 |
| 240000793 | 240000793 | 1.89 | 70.6 | 03 | null | 2017-10-24 | CHOP | 02 | N | DA | 101264579 |
| 240000796 | 240000796 | 1.45 | null | Curative (C) | null | 2019-02-10 | null | 02 | N | NHL 2003 GP B COP | 100588325 |
| 240000799 | 240000799 | null | null | null | null | 2019-07-30 | AML 19 TRIAL | null | null | NOT MATCHED | 100777638 |
| 240000804 | 240000804 | 0 | 86.65 | Disease modification (D) | null | 2019-10-07 | AML 18 Pilot Trial | 02 | N | FCR | 100944681 |
| 240000805 | 240000805 | null | null | null | null | 2019-11-21 | ALL UKALL2011 IndB Std Dex (PegAsp) | null | null | CHLORAMBUCIL + OBINUTUZUMAB | 100894402 |
| 240000815 | 240000815 | 1.74 | 86.75 | Palliative (P) | null | 2019-02-23 | null | N | null | AML MYECHILD 01 IT CYT | 100874344 |
| 240000816 | 240000816 | 1.67 | 96.2 | Palliative (P) | null | 2018-05-01 | Hydroxycarbamide | 1 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101346976 |
| 240000820 | 240000820 | 1.65 | 60.8 | Palliative (P) | 2017-07-16 | 2017-07-16 | null | null | N | DA | 101028775 |
| 240000825 | 240000825 | 1.72 | 76.3 | null | null | 2018-06-29 | Trial Unspecified | 02 | N | HYDROXYCARBAMIDE | 101281193 |
| 240000837 | 240000837 | null | null | null | null | 2019-01-27 | BENDAMUSTINE + CYTARABINE + RITUXIMAB | null | null | CYTARABINE + FLUDARABINE + IDARUBICIN | 100962394 |
| 240000840 | 240000840 | 1.63 | 117 | Adjuvant (A) | null | 2019-02-25 | null | 1 | N | AML18 TRIAL | 100467052 |